Market Cap 820.60M
Revenue (ttm) 183.50M
Net Income (ttm) -13.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7.22%
Debt to Equity Ratio 0.90
Volume 25,900
Avg Vol 89,750
Day's Range N/A - N/A
Shares Out 85.93M
Stochastic %K 14%
Beta 1.86
Analysts Strong Sell
Price Target $13.28

Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-a...

Industry: Biotechnology
Sector: Healthcare
Phone: 33 2 28 07 37 10
Fax: 33 2 28 07 37 11
Website: valneva.com
Address:
6 rue Alain Bombard, Saint-Herblain, France
TheCheeseWrangler
TheCheeseWrangler Oct. 27 at 5:02 PM
$VALN https://valneva.com/press-release/valneva-to-present-and-hold-investor-meetings-at-upcoming-u-s-and-european-healthcare-conferences-2/
1 · Reply
Creisi
Creisi Oct. 27 at 4:54 PM
$VALN current price means very little as the stock has virtually no volume. With such low volume, news in either direction can have major consequences on price. With Lyme Disease Clinical Trial News due this quarter; I expect a spike in buying pressure coinciding with sharp price increase; compounded by this extremely low volume of daily stock sales.
0 · Reply
OliviaEatz_
OliviaEatz_ Oct. 27 at 11:37 AM
$VALN hold ratings
0 · Reply
PickelballPaul
PickelballPaul Oct. 15 at 10:55 PM
$VALN First locally reported case of mosquito transmitted chikungunya virus in years in New York today
1 · Reply
Doozio
Doozio Oct. 15 at 9:36 PM
$VALN 👀 MAMA moar cup n handle for da 🧠 to spread TTWO 🐒🍌🧠⏰♾️
1 · Reply
Siuolman58
Siuolman58 Oct. 15 at 9:39 AM
$VALN 💎 $VALN 🔬 Chikungunya setback is baked in. Now the market’s sleeping on Lyme & Shigella upside. If VLA15 Phase III shows signs of life (or any favorable interim readout), this could rip. Accumulate this pain — small float, huge asymmetry. 🚀
0 · Reply
TheCheeseWrangler
TheCheeseWrangler Oct. 13 at 9:17 AM
$VALN €2.64 average , I've averaged down since Corona days & kept adding. Mid-2026 should be one hell of a payday 😉
0 · Reply
Siuolman58
Siuolman58 Oct. 9 at 11:03 PM
$VALN Pfizer buyout possibility?
1 · Reply
Creisi
Creisi Oct. 9 at 4:44 PM
$VALN It amazes me that no one in North America realizes how tremendous a LYME Vaccine will be come springtime. Everyone with a pet, everyone that goes to a park, hikes, camps or does any outside activity like gardening will be getting this vaccine. The market is far greater than analysts realize. I was projecting this stock to be $25 in spring of 2026. I can push that further, and see it passing $40 by June 2026, no problem whatsoever. This is perhaps the safest biopharma stock anyone can buy right now. Tremendous stock to buy, hold for June 2026, and then reap massive profits... I see you VALN and I'm loading up as much as I can.
2 · Reply
Creisi
Creisi Oct. 7 at 6:19 PM
$VALN This stock will soar past $25 come 1st quarter 2026, especially with the LYME disease Pfizer deal. Closest thing to a sure bet that there is on the market today.
0 · Reply
Latest News on VALN
Johnson Fistel Investigates Valneva Following FDA Suspension

Aug 25, 2025, 10:43 AM EDT - 2 months ago

Johnson Fistel Investigates Valneva Following FDA Suspension


FDA suspends Valneva's chikungunya vaccine license in the U.S.

Aug 25, 2025, 1:16 AM EDT - 2 months ago

FDA suspends Valneva's chikungunya vaccine license in the U.S.


Valneva SE (VALN) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 3:20 PM EDT - 2 months ago

Valneva SE (VALN) Q2 2025 Earnings Call Transcript


UK's MHRA suspends Valneva's chikungunya vaccine for elderly

Jun 9, 2025, 10:29 AM EDT - 5 months ago

UK's MHRA suspends Valneva's chikungunya vaccine for elderly


Valneva SE (VALN) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:47 AM EDT - 6 months ago

Valneva SE (VALN) Q1 2025 Earnings Call Transcript


Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

Apr 14, 2025, 2:28 PM EDT - 7 months ago

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine


Valneva SE Shareholding Declaration - March 2025

Apr 3, 2025, 11:45 AM EDT - 7 months ago

Valneva SE Shareholding Declaration - March 2025


Valneva SE (VALN) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:00 PM EDT - 7 months ago

Valneva SE (VALN) Q4 2024 Earnings Call Transcript


TheCheeseWrangler
TheCheeseWrangler Oct. 27 at 5:02 PM
$VALN https://valneva.com/press-release/valneva-to-present-and-hold-investor-meetings-at-upcoming-u-s-and-european-healthcare-conferences-2/
1 · Reply
Creisi
Creisi Oct. 27 at 4:54 PM
$VALN current price means very little as the stock has virtually no volume. With such low volume, news in either direction can have major consequences on price. With Lyme Disease Clinical Trial News due this quarter; I expect a spike in buying pressure coinciding with sharp price increase; compounded by this extremely low volume of daily stock sales.
0 · Reply
OliviaEatz_
OliviaEatz_ Oct. 27 at 11:37 AM
$VALN hold ratings
0 · Reply
PickelballPaul
PickelballPaul Oct. 15 at 10:55 PM
$VALN First locally reported case of mosquito transmitted chikungunya virus in years in New York today
1 · Reply
Doozio
Doozio Oct. 15 at 9:36 PM
$VALN 👀 MAMA moar cup n handle for da 🧠 to spread TTWO 🐒🍌🧠⏰♾️
1 · Reply
Siuolman58
Siuolman58 Oct. 15 at 9:39 AM
$VALN 💎 $VALN 🔬 Chikungunya setback is baked in. Now the market’s sleeping on Lyme & Shigella upside. If VLA15 Phase III shows signs of life (or any favorable interim readout), this could rip. Accumulate this pain — small float, huge asymmetry. 🚀
0 · Reply
TheCheeseWrangler
TheCheeseWrangler Oct. 13 at 9:17 AM
$VALN €2.64 average , I've averaged down since Corona days & kept adding. Mid-2026 should be one hell of a payday 😉
0 · Reply
Siuolman58
Siuolman58 Oct. 9 at 11:03 PM
$VALN Pfizer buyout possibility?
1 · Reply
Creisi
Creisi Oct. 9 at 4:44 PM
$VALN It amazes me that no one in North America realizes how tremendous a LYME Vaccine will be come springtime. Everyone with a pet, everyone that goes to a park, hikes, camps or does any outside activity like gardening will be getting this vaccine. The market is far greater than analysts realize. I was projecting this stock to be $25 in spring of 2026. I can push that further, and see it passing $40 by June 2026, no problem whatsoever. This is perhaps the safest biopharma stock anyone can buy right now. Tremendous stock to buy, hold for June 2026, and then reap massive profits... I see you VALN and I'm loading up as much as I can.
2 · Reply
Creisi
Creisi Oct. 7 at 6:19 PM
$VALN This stock will soar past $25 come 1st quarter 2026, especially with the LYME disease Pfizer deal. Closest thing to a sure bet that there is on the market today.
0 · Reply
Siuolman58
Siuolman58 Oct. 7 at 9:09 AM
$VALN Buy on Lyme!!!
0 · Reply
ajmore
ajmore Oct. 7 at 7:18 AM
$VALN opporrunity to buy, the new guidance hardly differs from previous one and lyme data is due.
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 6 at 4:52 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 3 at 9:16 AM
$VALN Excellent article that nails exactly where VALN stands right now. So if you want to update your VALN knowledge or get acquainted with VALN, this is a must read. https://beyondspx.com/quote/VALN/analysis/valneva-s-vaccine-renaissance-lyme-catalyst-and-chikungunya-s-resilient-path-nasdaq-valn
0 · Reply
ajmore
ajmore Oct. 1 at 11:29 AM
$VALN pfizer's deal with trump, yesterday, gives pfizer 5 years exempt from tarrifs on any product they sell that is manufactured outside the US.
0 · Reply
Riderman29
Riderman29 Oct. 1 at 11:10 AM
$VALN 7% up in Europe, continue strong uptrend
0 · Reply
Papusa
Papusa Oct. 1 at 8:45 AM
$VALN Production USA or EU for Lyme?
1 · Reply
Papusa
Papusa Oct. 1 at 8:44 AM
$VALN does anyone know where will be Lyme produced? In EU or USA? In which production plant?
0 · Reply
ajmore
ajmore Oct. 1 at 7:34 AM
$VALN further thoughts on the 4 year serotype update! commercially: this makes valneva's vaccine first choice. 4 year immunogenicity is cost effective, enhances the herd immunity and lowers risks associated with repetitive vaccinations. Platform: have we got something that can go further, I mean flu vaccines... Large Pharma watching. impressive development.
0 · Reply
topstockalerts
topstockalerts Sep. 30 at 12:10 PM
$VALN setting up nicely.. 🍾
0 · Reply
G101SPM
G101SPM Sep. 30 at 11:12 AM
$VALN $11.80 ask. BUY/NEW LONG POSITION carries SPM 87.06 tag to $25.00 in midterm.
0 · Reply
DaxCo
DaxCo Sep. 30 at 10:41 AM
$VALN 💥↗️ 🔋
0 · Reply